- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-KLF2
KLF2 Polyclonal Antibody for WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IP, CoIP, ChIP, ELISA
Conjugaison
Non conjugué
N° de cat : 23384-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HepG2, cellules bEnd.3 |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 5 publications below |
| IP | See 1 publications below |
| CoIP | See 1 publications below |
| ChIP | See 2 publications below |
Informations sur le produit
23384-1-AP cible KLF2 dans les applications de WB, IP, CoIP, ChIP, ELISA et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Réactivité citée | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | KLF2 Protéine recombinante Ag20019 |
| Nom complet | Kruppel-like factor 2 (lung) |
| Masse moléculaire calculée | 355 aa, 37 kDa |
| Poids moléculaire observé | 37-40 kDa, 60 kDa |
| Numéro d’acquisition GenBank | BC071983 |
| Symbole du gène | KLF2 |
| Identification du gène (NCBI) | 10365 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purifié par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
KLF2 (Kruppel-like Factor 2) belongs to zinc finger transcription factors, and it is implicated in a variety of biochemical processes, including lung development, embryonic erythropoiesis, epithelial integrity, T-cell viability, and adipogenesis (PMID: 17904406). KLF2 was identified as a negative regulator of T cell activation and adipogenesis. KLF2 also acts as a novel regulator of endothelial proinflammatory activation, inhibiting the inflammatory cytokine-mediated induction of adhesion molecule expression and immune cell adhesion (PMID:15718498). KLF2-null mice exhibit abnormal blood vessel formation, resulting in embryonic haemorrhage and death (PMID: 32132543). KLF2 can be detected 60 kDa by post-translationally modified (PMID: 36466816).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for KLF2 antibody 23384-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
J Cardiothorac Surg Mechanism of KLF2 in young mice with pneumonia induced by Streptococcus pneumoniae | ||
Drug Dev Res KLF2 Inhibits Ferroptosis and Improves Mitochondrial Dysfunction in Chondrocyte Through SIRT1/GPX4 Signaling to Improve Osteoarthritis | ||
J Cell Mol Med Single-cell and spatial transcriptomics reveal apelin/APJ pathway's role in microvessel formation and tumour progression in hepatocellular carcinoma | ||
J Orthop Surg Res A novel mechanism in regulating drug sensitivity, growth, and apoptosis of bortezomib-resistant multiple myeloma cells: the USP4/KLF2/HMGA2 cascade | ||
Theranostics Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m6A modification in atherosclerosis |
